CA Stock MarketDetailed Quotes

GTTX GeneTether Therapeutics Inc

Watchlist
  • 0.045
  • +0.005+12.50%
15min DelayMarket Closed Dec 13 10:13 ET
1.74MMarket Cap-3.21P/E (TTM)

About GeneTether Therapeutics Inc Company

GeneTether Therapeutics Inc is a genetic medicines company focused on the development of high-efficiency precision gene editing for human therapeutics applications. It is engaged in creating gene-editing therapies based on the proprietary GeneTether platform. Further, it is focused on building a discovery pipeline for the treatment of rare, monogenic diseases of the kidney and the skin. Their platform is designed to increase the efficiency of genome editing technologies, including CRISPR-Cas, TALENs, and ZFNs.

Company Profile

SymbolGTTX
Company NameGeneTether Therapeutics Inc
Founded2021
MarketCNQ
Fiscal Year Ends12-31
Address301-1665 Ellis Street c/o Pushor Mitchell LLP
CityKelowna
CountryCAN
Zip CodeX1X 1X1
Phone+1 833 294-4363

Company Executives

No Data